Aberrant E-cadherin expression associated with loss of differentiation andadvanced stage in human pancreatic cancer

Citation
Aj. Karayiannakis et al., Aberrant E-cadherin expression associated with loss of differentiation andadvanced stage in human pancreatic cancer, ANTICANC R, 18(6A), 1998, pp. 4177-4180
Citations number
31
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
ANTICANCER RESEARCH
ISSN journal
02507005 → ACNP
Volume
18
Issue
6A
Year of publication
1998
Pages
4177 - 4180
Database
ISI
SICI code
0250-7005(199811/12)18:6A<4177:AEEAWL>2.0.ZU;2-N
Abstract
E-cadherin is a cell-cell adhesion molecule involved in armour invasion and metastasis. We evaluated E-cadherin expression immunohistochemically in 43 formalin-fixed, paraffin-embedded specimens of pancreatic cancer and inves tigated its relationship to histopathological features. In noncancerous pan creatic cells E-cadherin immunoreactivity was localized at the cell membran e, particularly at the intercellular junctions. Abnormal E-cadherin express ion was found in 18 (42%) cases. A significantly higher proportion of poorl y-differentiated tumours (71%) showed abnormal E-cadherin expression compar ed with moderately (50%) and well (19%) differentiated tumours (P=0.037). T here was a significant correlation between abnormal E-cadherin expression a nd lymph node involvement (P=0.013), the presence of distant metastases (P= 0.034) and advanced tumour stage (P=0.025). These findings suggest that los s of normal E-cadherin expression is involved in the progression of pancrea tic cancer.